<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034211</url>
  </required_header>
  <id_info>
    <org_study_id>342/25/5/21</org_study_id>
    <nct_id>NCT05034211</nct_id>
  </id_info>
  <brief_title>A Comparison Between 2 Methods of Local Anesthetic Administration for Maintaining Labor Analgesia After Dural Puncture Epidural</brief_title>
  <official_title>A Comparison Between 2 Methods of Local Anesthetic Administration for Maintaining Labor Analgesia After Dural Puncture Epidural</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aretaieio Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aretaieio Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intermittent epidural bolus technique opens a new era of interest for maintaining labor&#xD;
      anlagesia. The study examines programmed intermittent epidural bolus technique on a scheduled&#xD;
      basis to provider-administered bolus anlgesia on patient request, after a dural puncture&#xD;
      epidural technique.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After dural puncture, an epidural catheter will be placed on nulliparous women between 38 and&#xD;
      40 weeks of gestation presenting for labor . All will receive an test dose of 3ml lidocaine&#xD;
      2%, for properly checking the catheter placement and then an initial dose of 10ml ropivacaine&#xD;
      0,2% with 2 mcg/ml fentanyl. After that, women will be randomly assigned on two groups. Both&#xD;
      groups will be receiving the same dose of analgesia (10ml ropivacaine 0,2% plus 1,5 mcg/ml&#xD;
      fentanyl. However, one group will be receiving them on scheduled time intervals as programmed&#xD;
      intermittent boluses every 60minutes and the other only on patient request for pain relief.&#xD;
&#xD;
      Pain scores, satisfaction, time for adequate analgesia, bromage scores,apgar scores, fetal&#xD;
      arterial blood gases, time for delivery and type of delivery will be studied&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total local anesthetic and opioid administration</measure>
    <time_frame>24hours</time_frame>
    <description>the total mg of local anesthetic and opioid consumed via the epidural catheter until the neonate delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time needed for delivery</measure>
    <time_frame>24hours</time_frame>
    <description>how long will it take for the baby to be delivered(in minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total patient satisfaction</measure>
    <time_frame>24hours</time_frame>
    <description>from a scale of 0 to 10, higher score signifies better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>apgar score</measure>
    <time_frame>24hours</time_frame>
    <description>a test given to newborns soon after birth. This test checks a baby's heart rate, muscle tone, and other signs to see if extra medical care or emergency care is needed. The test is usually given twice: once at 1 minute after birth, and again at 5 minutes after birth.The higher the score the better the baby's condition willl be (the scale is from 0 to 10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bromage score</measure>
    <time_frame>24hours</time_frame>
    <description>This scale assesses the intensity of motor block by the patient's ability to move their lower extremities. O signifies free movement and 4 complete paralysis(higher score means worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of delivery</measure>
    <time_frame>24hours</time_frame>
    <description>whether it will be vaginal delivery, vaginal assisted delivery with instruments or a cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal arterial blood gases</measure>
    <time_frame>24hours</time_frame>
    <description>when the baby will be delivered, a neonatal arterial blood gas will be measured</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time for sucessful level of analgesia</measure>
    <time_frame>24hours</time_frame>
    <description>the time needed after epidural bolus to reach a scale below 3 on the NRS scale for pain assesment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score(NRS scale)</measure>
    <time_frame>24hours</time_frame>
    <description>n a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10 . O represents no pain and 10 the worst pain ever possible</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Labor Pain</condition>
  <condition>Epidural</condition>
  <condition>Pain, Labor</condition>
  <arm_group>
    <arm_group_label>Programmed intermittent Bolus Epidural technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10ml ropivacaine 0,2% and 1,5 mcg/ml fentanyl, will be administered every 60 minutes via an epidural catheter placed for labor analgesia on L2-L3/L3-L4 level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Provider administered bolus epidural technique on patient request</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10ml ropivacaine 0,2% and 1,5 mcg/ml fentanyl, will be administered by the provider on patient request</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Programmed intermittent bolus epidural</intervention_name>
    <description>one arm will receive programmed intermittent boluses of local anesthetic via the epidural catheter on fixed time intervals. Standard 27G Tuohy needle epidural set with epidural catheter insertion on L2-L3 site, with the patient either sitting or in the lateral decubitus position will be used. Local injection with 6 ml lidocaine 2% will be performed before the insertion of the epidural needle</description>
    <arm_group_label>Programmed intermittent Bolus Epidural technique</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Provider administered analgesia on patient request</intervention_name>
    <description>one arm will receive bolus of local anesthetic via the catheter upon patient request. Standard 27G Tuohy needle epidural set with epidural catheter insertion on L2-L3 site, with the patient either sitting or in the lateral decubitus position will be used. Local injection with 6 ml lidocaine 2% will be performed before the insertion of the epidural needle</description>
    <arm_group_label>Provider administered bolus epidural technique on patient request</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -nulliparous women&#xD;
&#xD;
          -  38th week of gestation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient refusal to have an epidural&#xD;
&#xD;
          -  patient refusal to participate&#xD;
&#xD;
          -  contraindication for epidural&#xD;
&#xD;
          -  ASA&gt;3&#xD;
&#xD;
          -  neurologic deficit/impairment&#xD;
&#xD;
          -  allergy on local anesthetic chronic pain syndromes&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anteia Paraskeva, Dr</last_name>
    <phone>306972868078</phone>
    <email>aparask@med.uoa.gr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Polyxeni Theodosopoulou, MD</last_name>
    <email>xeniathd@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aretaieio Hospital</name>
      <address>
        <city>Athens</city>
        <state>Attiki</state>
        <zip>11528</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anteia Paraskeva, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>Polyxeni Theodosopoulou, MD</last_name>
      <email>xeniathd@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 15, 2021</study_first_submitted>
  <study_first_submitted_qc>August 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 28, 2021</last_update_submitted>
  <last_update_submitted_qc>August 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aretaieio Hospital</investigator_affiliation>
    <investigator_full_name>Polyxeni Theodosopoulou</investigator_full_name>
    <investigator_title>Resident anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>dural puncture</keyword>
  <keyword>programmed intermittent bolus</keyword>
  <keyword>labor analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

